Tuesday, Feb 20 2018 | Time 15:21 Hrs(IST)
image
image image
  • Trump blames Obama for inaction over Russia meddling
  • Cabinet approves doubling, electrification of Bhatni-Aurnihar line
  • Cabinet gives nod to Silkyara Bend-Barkot tunnel in Uttarkhand
  • Cabinet approves six-laning of Nidagatta-Mysuru sec in Karnataka
  • Iran finds wreckage of crashed plane on top of mountain
  • Mahadalit lynched in Bihar
  • Khaleda committed crime by embezzling Trust fund: Court
  • CM hits back at Rajnath on Meghalaya’s law and order situation
  • Maldives police arrest 25 after protest demanding leader's arrest
  • Campaign takes pace in poll-bound Meghalaya; politicians make beeline to woo voters
  • Maldives leader seeks approval to extend state of emergency
  • Chinese warships enter East Indian Ocean amid Maldives tensions
  • Fire in battery factory in Patparganj
  • 3 years on, Justice for Govind Pansare remains elusive
  • Reference rate fixed at 64 5254 against USD
Science Technology Share

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

MedGenome launches liquid biopsy blood test 'Oncotrack' for  cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring. The Oncotrack is a non-invasive screening test that is set to transform the way physicians in India can identify genetic alterations, interpret, assess and treat various forms of cancers. Launching the blood test yesterday, Chief operation officer of MedGenome, Dr V L Ramprasad said, 'Liquid biopsy has the capacity to interpret infinite mutations which will pave the way for new drug discovery, research and therapies. Over 35 oncologists in India have already screened patients using our Oncotrack. Further, since it has a very patient-friendly approach, we are confident it will be very well accepted by both the doctors and patients.' India is likely to have over 1.73 million new cases of cancer and over 8,80,000 deaths due to the disease by 2020. Around 70 per cent of all cancer patients approach the doctor when the disease has advanced, and the chances of cure are very low. 'Management of cancer will undergo a massive transformation in India with NGS-based liquid biopsies. We are constantly striving to get the most advanced genetic testing technology/ technique at affordable prices to the patients and Oncotrack is one such offering,' said Sam Santhosh, chairman, MedGenome. The test, developed entirely by MedGenome, is the only one to be validated in India and verified from samples of cancer patients from across the country. The test screens the samples by analyzing cell-free DNA that is isolated from the patients’ blood. Using high-end sequencing technology, the screening process identifies specific gene mutations that are linked with Melanoma, Lung and Colon cancers. The test facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy. This offers oncologists the power to look for actionable alterations in a patient's treatment, management, without having to do an invasive biopsy or where biopsy is not an option. Oncotrack is a proven molecular tool after histopathology diagnosis and detecting molecular changes at baseline and at the time of relapse in lung and colon cancer for deciding the right treatment. The test has been validated in a scientific study, in academic collaboration with Tata Memorial Hospital -- Dr Kumar Prabhash, medical oncologist, and Dr Amit Dutt, principal investigator (Scientist F) at ACTREC, Tata Memorial Centre. UNI ST SS RSA SB 1043

More News
Musculoskeletal conditions, second largest contributor to disability worldwide

Musculoskeletal conditions, second largest contributor to disability worldwide

19 Feb 2018 | 12:15 PM

Kolkata, Feb 19 (UNI) Musculoskeletal conditions are the second largest contributor to disability worldwide, with lower back pain being the single leading cause of disability globally.

 Sharesee more..
250 Renal Transplants conducted at SKIMS

250 Renal Transplants conducted at SKIMS

17 Feb 2018 | 5:11 PM

Srinagar, Feb 17 (UNI) The department of Urology and Kidney Transplant Unit (KTU) at the Sher-I-Kashmir Institute of Medical Sciences (SKIMS) has successfully conducted record 250 kidney transplants till date, making it at par with any other centre in the country, an officiual of the institute said here on Saturday.

 Sharesee more..
Individualized, supportive care key to positive childbirth experience: WHO

Individualized, supportive care key to positive childbirth experience: WHO

16 Feb 2018 | 12:02 PM

Kolkata, Feb 16 (UNI) The World Health Organisation (WHO) has issued new recommendations to establish global care standards for healthy pregnant women and reduce unnecessary medical interventions.

 Sharesee more..
Pneumonia, a form of acute respiratory infection that affects lungs

Pneumonia, a form of acute respiratory infection that affects lungs

14 Feb 2018 | 11:57 AM

Kolkata, Feb 14 (UNI) Pneumonia is a form of acute respiratory infection that affects the
lungs.

 Sharesee more..
WHO releases its 2018 Blueprint list of priority diseases

WHO releases its 2018 Blueprint list of priority diseases

13 Feb 2018 | 12:37 PM

Kolkata, Feb 13 (UNI) The World Health organization ( WHO) releases its 2018 list of priority pathogens that have the potential to cause a public health emergency and which have no, or insufficient, countermeasures.

 Sharesee more..
image